Berkshire profit rises, cash soars to record

Berkshire Hathaway reported a record $381.7 billion cash reserve in its latest financial report, preceding Warren Buffett's transition from CEO, signaling continued market caution as the conglomerate was a net seller of stocks for the 12th consecutive quarter and abstained from share buybacks. Third-quarter operating profit increased 34% to $13.49 billion, while net income rose 17% to $30.8 billion. With Greg Abel set to take over as CEO, the substantial cash pile and the company's recent underperformance against the S&P 500 raise questions about future capital allocation strategies, including potential dividends or significant acquisitions like the announced $9.7 billion OxyChem deal.

Analysis

Berkshire Hathaway concluded its latest reporting period with a record $381.7 billion in cash, signaling continued market caution as it was a net seller of stocks for the 12th consecutive quarter and abstained from share repurchases for the fifth consecutive quarter. This substantial capital accumulation precedes Warren Buffett's transition from CEO, with Greg Abel set to assume leadership. The company's equity portfolio, valued at $283.2 billion, saw net selling, indicating a defensive posture.

Third-quarter operating profit increased 34% year-over-year to $13.49 billion, primarily driven by lower loss projections in its insurance and reinsurance segments, despite Geico's lower underwriting gains. Net income, including investment gains, rose 17% to $30.8 billion, though Buffett typically downplays this metric due to its volatility from unrealized stock gains. The company also announced a $9.7 billion acquisition of Occidental Petroleum's OxyChem business in early October.

Investor apprehension regarding Berkshire's outlook and impending management change is evident, with the stock price falling 12% since May 3rd and trailing the S&P 500 by 32 percentage points. The substantial cash reserve, coupled with the lack of buybacks and net selling, suggests a conservative stance amidst this leadership transition, raising questions about future capital deployment under Abel's leadership.

Key Decisions for Investors

• Monitor Greg Abel's capital allocation strategy closely, particularly regarding the deployment of the $381.7 billion cash pile for potential dividends or significant acquisitions beyond the announced OxyChem deal.
• Evaluate the impact of Berkshire's sustained market caution and lack of share buybacks on shareholder value, especially given its recent underperformance against broader market indices.
• Assess the implications of the leadership transition on Berkshire's long-term investment philosophy and portfolio construction under Abel's more hands-on management style.